Introduction and Welcome
P. Hassoun (Baltimor, United States of America)
|   |
The pro-proliferative phenotype of pulmonary microvascular endothelium
T. Stevens (Mobile, United States of America)
| |
Smooth muscle cell heterogeneity and transdifferentiation
K. Stenmark (Denver, United States of America)
| |
Cytokines and chemokines in pulmonary vascular remodelling
M. Humbert (Clamart, France)
| |
Inflammation and the plexiform lesion
N. Voelkel (Denver, United States of America)
| |
Systemic neovascularization of the lung after left pulmonary artery obstruction
E. Wagner (Baltimor, United States of America)
| |
Imaging of angiogenesis
D. McDonald (San Francisco, United States of America)
| |
Role of progenitor cells in lung vascular repair: A novel approach for the treatment of pulmonary hypertension
D. Stewart (Queen Wing Toronto, Canada)
| |
The dual role of apoptosis in pulmonary hypertension
R. Tuder (Baltimore, United States of America)
| |
BMP receptor-dependent control of matrix production in PAH
P. Jones (Philadelphia, United States of America)
| |
Endothelial control of BMPR2 signalling in experimental shunt-induced pulmonary arterial hypertension
R. Naeije (Brussels, Belgium)
| |
Relationship of BMPR2 mutations and vasoreactivity in pulmonary arterial hypertension
C. Elliott (Salt Lake City, United States of America)
| |
Serotonin and pulmonary vascular remodelling
S. Adnot (Creteil, France)
| |
The genetics of pulmonary arterial hypertension
R. Trembath (Leicester, United Kingdom)
| |
Lessons from transgenic models of pulmonary hypertension
D. Rodman (Horsham, United Kingdom)
| |
Right Ventricular Failure in an Animal Model of Severe Pulmonary Arterial Hypertension: eNOS Uncoupling and Protein Kinase G Signaling in the Transition from Adaptive to Maladaptive Remodeling
M. Crow (Baltimore, United States of America)
| |
A Disordered Mitochondria-HIF-Kv Pathway Contributes to PAH in Fawn Hooded Rats and Humans
S. Archer (Edmonton, Canada)
| |